Kyocera has developed a new ultra-thin meta-lens that can shift focal positions depending on the wavelength of light.
Pivotal Phase 3 trial of MO-03 builds on prior studies that demonstrated enhanced immunotherapy benefit without added ...
Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
Epicrispr, a clinical-stage company pioneering gene-modulating therapies, today reported early clinical data from its ongoing ...
Addressing the core issues of latency and integration in developing audio amplifiers for today’s smart cockpits.
Controlling light is an important technological challenge—not just at the large scale of optics in microscopes and telescopes ...
Light can be sculpted into countless shapes. Yet building optical devices that can simultaneously manipulate many different ...
Every summer, our cities burn energy to keep us cool. The same happens in winter with the increasing demand for heating.
Researchers have built a new platform that produces ultrashort UV-C laser pulses and detects them at room temperature using ...
Most of today's quantum computers rely on qubits with Josephson junctions that work for now but likely won't scale as needed ...